RE:Earnings Release ScheduledIt won't be the Q4 earnings that will be of primary importance to me, although there might be some Tibella revenue plus a small amount of revenue from initial filling up of the supply chain from Combogesic. The important thing for me will be the CEO's commentary on the potential take-up of Combogesic. Of course, launching new products during a pandemic can't be easy, but still...